200 related articles for article (PubMed ID: 20362334)
1. CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma.
Jevremovic D; Dronca RS; Morice WG; McPhail ED; Kurtin PJ; Zent CS; Hanson CA
Leuk Res; 2010 Sep; 34(9):1235-8. PubMed ID: 20362334
[TBL] [Abstract][Full Text] [Related]
2. [The immunophenotypic characteristics of 260 patients with CD5 + B cell lymphoproliferative disorders].
Yi S; Li Z; Wang H; Liu W; Lyu R; Yu Z; Qi J; Qiu L
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):337-41. PubMed ID: 24759024
[TBL] [Abstract][Full Text] [Related]
3. [Differential malignant lymphoproliferative syndrome (LPS) diagnosis with flow cytometry: a study of 100 patients].
Cardile N; Sabo G; Butsch P; Brengarth E; Viollier AF; Knecht H
Praxis (Bern 1994); 2000 Jan; 89(4):143-9. PubMed ID: 10686807
[TBL] [Abstract][Full Text] [Related]
4. Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias.
Ho AK; Hill S; Preobrazhensky SN; Miller ME; Chen Z; Bahler DW
Am J Clin Pathol; 2009 Jan; 131(1):27-32. PubMed ID: 19095562
[TBL] [Abstract][Full Text] [Related]
5. CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Palumbo GA; Parrinello N; Fargione G; Cardillo K; Chiarenza A; Berretta S; Conticello C; Villari L; Di Raimondo F
Leuk Res; 2009 Sep; 33(9):1212-6. PubMed ID: 19230971
[TBL] [Abstract][Full Text] [Related]
6. Effect of interleukin-2 on CD95 (Fas/APO-1) expression in fresh chronic lymphocytic leukaemia and mantle cell lymphoma cells: relationship to ex vivo chemoresponse.
Bosanquet AG; Bell PB; Rooney N
Anticancer Res; 1999; 19(6B):5329-34. PubMed ID: 10697557
[TBL] [Abstract][Full Text] [Related]
7. The cut-off levels of CD23 expression in the differential diagnosis of MCL and CLL.
Barna G; Reiniger L; Tátrai P; Kopper L; Matolcsy A
Hematol Oncol; 2008 Sep; 26(3):167-70. PubMed ID: 18381689
[TBL] [Abstract][Full Text] [Related]
8. The CD5+ B-cell.
Dono M; Cerruti G; Zupo S
Int J Biochem Cell Biol; 2004 Nov; 36(11):2105-11. PubMed ID: 15313456
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of a new CD5 antibody for the diagnosis of T-cell and B-cell lymphoproliferative disorders in paraffin sections.
Dorfman DM; Shahsafaei A
Mod Pathol; 1997 Sep; 10(9):859-63. PubMed ID: 9310947
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
Cabezudo E; Carrara P; Morilla R; Matutes E
Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
[TBL] [Abstract][Full Text] [Related]
11. CD5-negative, CD10-negative small B-cell leukemia: variant of chronic lymphocytic leukemia or a distinct entity?
Sheikh SS; Kallakury BV; Al-Kuraya KA; Meck J; Hartmann DP; Bagg A
Am J Hematol; 2002 Dec; 71(4):306-10. PubMed ID: 12447961
[TBL] [Abstract][Full Text] [Related]
12. D cyclins in CD5+ B-cell lymphoproliferative disorders: cyclin D1 and cyclin D2 identify diagnostic groups and cyclin D1 correlates with ZAP-70 expression in chronic lymphocytic leukemia.
Meyerson HJ; MacLennan G; Husel W; Cocco A; Tse W; Lazarus HM; Kaplan D
Am J Clin Pathol; 2006 Feb; 125(2):241-50. PubMed ID: 16393687
[TBL] [Abstract][Full Text] [Related]
13. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
14. CD5- B-cell lymphoproliferative disorders presenting in blood and bone marrow. A clinicopathologic study of 40 patients.
Shapiro JL; Miller ML; Pohlman B; Mascha E; Fishleder AJ
Am J Clin Pathol; 1999 Apr; 111(4):477-87. PubMed ID: 10191767
[TBL] [Abstract][Full Text] [Related]
15. Guess what: Chronic 13q14.3+/CD5-/CD23+ lymphocytic leukemia in blood and t(11;14)(q13;q32)+/CD5+/CD23- mantle cell lymphoma in lymph nodes!
Lima M; Pinto L; Dos Anjos Teixeira M; Canelhas A; Mota A; Cabeda JM; Silva C; Queirós ML; Fonseca S; Santos AH; Brochado P; Justiça B
Cytometry B Clin Cytom; 2003 Jan; 51(1):41-4. PubMed ID: 12500296
[TBL] [Abstract][Full Text] [Related]
16. The CD45 isoform B220 identifies select subsets of human B cells and B-cell lymphoproliferative disorders.
Rodig SJ; Shahsafaei A; Li B; Dorfman DM
Hum Pathol; 2005 Jan; 36(1):51-7. PubMed ID: 15712182
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism in the CD5 gene promoter in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
Pérez-Chacón G; Contreras-Martín B; Cuní S; Rosado S; Martín-Donaire T; Losada-Fernández I; Vargas JA; Jordá J; Alvarez N; García-Marco J; Pérez-Aciego P
Am J Clin Pathol; 2005 May; 123(5):646-50. PubMed ID: 15981803
[TBL] [Abstract][Full Text] [Related]
18. Adhesion molecules in B-chronic lymphoproliferative disorders.
Angelopoulou MK; Kontopidou FN; Pangalis GA
Semin Hematol; 1999 Apr; 36(2):178-97. PubMed ID: 10319387
[TBL] [Abstract][Full Text] [Related]
19. [Relevance of cytological and immunophenotypical analysis for the diagnosis of B-cell chronic lymphocytic leukaemia].
Guillaume N; Alimardani G; Capiod JC; Claisse JF
Ann Biol Clin (Paris); 2002; 60(6):673-81. PubMed ID: 12446231
[TBL] [Abstract][Full Text] [Related]
20. The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
Matutes E; Owusu-Ankomah K; Morilla R; Garcia Marco J; Houlihan A; Que TH; Catovsky D
Leukemia; 1994 Oct; 8(10):1640-5. PubMed ID: 7523797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
